Literature DB >> 32357997

Coagulopathy associated with COVID-19.

Stephanie G Lee1, Michael Fralick1, Michelle Sholzberg2.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32357997      PMCID: PMC7259970          DOI: 10.1503/cmaj.200685

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  6 in total

1.  Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area.

Authors:  Safiya Richardson; Jamie S Hirsch; Mangala Narasimhan; James M Crawford; Thomas McGinn; Karina W Davidson; Douglas P Barnaby; Lance B Becker; John D Chelico; Stuart L Cohen; Jennifer Cookingham; Kevin Coppa; Michael A Diefenbach; Andrew J Dominello; Joan Duer-Hefele; Louise Falzon; Jordan Gitlin; Negin Hajizadeh; Tiffany G Harvin; David A Hirschwerk; Eun Ji Kim; Zachary M Kozel; Lyndonna M Marrast; Jazmin N Mogavero; Gabrielle A Osorio; Michael Qiu; Theodoros P Zanos
Journal:  JAMA       Date:  2020-05-26       Impact factor: 56.272

2.  Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy.

Authors:  Ning Tang; Huan Bai; Xing Chen; Jiale Gong; Dengju Li; Ziyong Sun
Journal:  J Thromb Haemost       Date:  2020-04-27       Impact factor: 5.824

3.  Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia.

Authors:  Ning Tang; Dengju Li; Xiong Wang; Ziyong Sun
Journal:  J Thromb Haemost       Date:  2020-03-13       Impact factor: 5.824

4.  Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia.

Authors:  Songping Cui; Shuo Chen; Xiunan Li; Shi Liu; Feng Wang
Journal:  J Thromb Haemost       Date:  2020-05-06       Impact factor: 5.824

5.  Incidence of thrombotic complications in critically ill ICU patients with COVID-19.

Authors:  F A Klok; M J H A Kruip; N J M van der Meer; M S Arbous; D A M P J Gommers; K M Kant; F H J Kaptein; J van Paassen; M A M Stals; M V Huisman; H Endeman
Journal:  Thromb Res       Date:  2020-04-10       Impact factor: 3.944

6.  Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.

Authors:  Fei Zhou; Ting Yu; Ronghui Du; Guohui Fan; Ying Liu; Zhibo Liu; Jie Xiang; Yeming Wang; Bin Song; Xiaoying Gu; Lulu Guan; Yuan Wei; Hui Li; Xudong Wu; Jiuyang Xu; Shengjin Tu; Yi Zhang; Hua Chen; Bin Cao
Journal:  Lancet       Date:  2020-03-11       Impact factor: 79.321

  6 in total
  29 in total

Review 1.  Anticipating and managing coagulopathy and thrombotic manifestations of severe COVID-19.

Authors:  Lucas C Godoy; Ewan C Goligher; Patrick R Lawler; Arthur S Slutsky; Ryan Zarychanski
Journal:  CMAJ       Date:  2020-08-16       Impact factor: 8.262

2.  Microthrombi in skin biopsy of a patient with COVID-19.

Authors:  Elona Shehi; Sridhar Chilimuri; Dongmin Shin; Madanmohan Patel; Nisha Ali; Masooma Niazi
Journal:  JAAD Case Rep       Date:  2020-10-13

3.  Axillary artery thrombosis resulting in upper limb amputation as a COVID-19 sequela.

Authors:  Riju Ramachandran; Anoop Vasudevan Pillai; Suyambu Raja; Sailakshmi Sailesh
Journal:  BMJ Case Rep       Date:  2021-01-26

Review 4.  Immune Response to SARS-CoV-2 Infection in Obesity and T2D: Literature Review.

Authors:  Jorge Pérez-Galarza; César Prócel; Cristina Cañadas; Diana Aguirre; Ronny Pibaque; Ricardo Bedón; Fernando Sempértegui; Hemmo Drexhage; Lucy Baldeón
Journal:  Vaccines (Basel)       Date:  2021-01-29

Review 5.  COVID-19 insights from transfusion medicine.

Authors:  Willy A Flegel
Journal:  Br J Haematol       Date:  2020-07-28       Impact factor: 8.615

6.  Blood component use in critical care in patients with COVID-19 infection: a single-centre experience.

Authors:  Andrew J Doyle; Anicee Danaee; Charlene I Furtado; Scott Miller; Tim Maggs; Susan E Robinson; Andrew Retter
Journal:  Br J Haematol       Date:  2020-10-21       Impact factor: 8.615

Review 7.  Thrombosis and Coagulopathy in COVID-19.

Authors:  Juan Esteban Gómez-Mesa; Stephania Galindo-Coral; Maria Claudia Montes; Andrés J Muñoz Martin
Journal:  Curr Probl Cardiol       Date:  2020-11-02       Impact factor: 5.200

Review 8.  Comprehensive Landscape of Heparin Therapy for COVID-19.

Authors:  Chen Shi; Wu Tingting; Jin-Ping Li; Mitchell A Sullivan; Cong Wang; Hanxiang Wang; Bin Deng; Yu Zhang
Journal:  Carbohydr Polym       Date:  2020-10-22       Impact factor: 10.723

9.  Leveraging genetic data to elucidate the relationship between Covid-19 and ischemic stroke.

Authors:  Verena Zuber; Alan Cameron; Evangelos P Myserlis; Leonardo Bottolo; Israel Fernandez-Cadenas; Stephen Burgess; Christopher D Anderson; Jesse Dawson; Dipender Gill
Journal:  medRxiv       Date:  2021-03-01

10.  Recurrence of Upper Extremity Deep Vein Thrombosis Secondary to COVID-19.

Authors:  Yesha H Parekh; Nicole J Altomare; Erin P McDonnell; Martin J Blaser; Payal D Parikh
Journal:  Viruses       Date:  2021-05-11       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.